PARKHOSPS283.00

Park Medi World Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersMAXHEALTHFORTISMEDANTAMETROPOLISMARKSANSRUBICONJLHLSHILPAMEDMcap ₹12,224 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations410.0460.4475.7
Other Income9.17.57.6
Total Income419.1467.9483.4
Expenses
+ Cost of Materials Consumed75.878.477.1
+ Changes in Inventories-0.11.2-0.9
+ Employee Benefit Expense83.186.292.4
+ Finance Costs14.914.09.8
+ Depreciation & Amortisation15.317.518.8
+ Other Expenses151.8167.3181.0
Total Expenses340.8364.5378.3
EBITDA99.4127.4126.1
EBIT84.1109.9107.2
Profit
PBT before Exceptional Items78.3103.4105.1
Pretax Income78.3103.4105.1
+ Current Tax19.119.825.8
+ Deferred Tax6.46.8-9.3
Tax Expense25.426.616.5
Net Income52.876.888.6
+ Net Income — Continuing Ops52.876.888.6
+ Other Comprehensive Income0.60.4-0.6
Total Comprehensive Income53.477.288.0
Net Income to Common50.870.982.5
Minority Interest2.15.96.1
Per Share
Basic EPS1.351.782.05
Diluted EPS1.351.782.05
Other Comprehensive Income — detail
+ Other Comprehensive Income0.60.4-0.6
+ Items NOT to be Reclassified to P&L0.70.4-0.8
+ Tax on Items NOT to be Reclassified0.20.0-0.2
Comprehensive Income — Owners of Parent51.371.2-0.6
Comprehensive Income — Non-controlling Interests2.15.9-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations1.351.782.05
Diluted EPS — Continuing Operations1.351.782.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit334.3380.8399.5
Gross Margin %81.5582.7183.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)78.3103.4105.1
Net Income Adj (tax-effected)52.876.888.6
EPS Adj1.351.782.05
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.00
Paid Up Equity Capital86.486.486.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.